-
361
Lymphoma of the Urinary Bladder
Published 2014-01-01“…MALT typically affects adults older than 60 years; 75% are female. Diffuse large B-cell lymphoma is also common and may arise from transformation of MALT. …”
Get full text
Article -
362
Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin’s Lymphoma
Published 2015-01-01“…We report a 72-year-old female patient with diffuse large B cell non-Hodgkin’s lymphoma (NHL) with previous treatment with standard chemotherapy presenting as an acute, ascending, sensorimotor polyneuropathy. …”
Get full text
Article -
363
A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)
Published 2019-05-01“…Nonetheless, research on novel therapies for effective treatment of MM is ongoing and in this case the involvement of Bruton’s tyrosine kinase (Btk) in B-cell malignancies has made it one of the new therapeutic targets. …”
Get full text
Article -
364
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
Published 2024-02-01“… Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell lymphoid neoplasia and, in some instances, improved disease outcomes. …”
Get full text
Article -
365
Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
Published 2022-01-01“…Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase (BTK) inhibitors approved for certain indolent B cell non-Hodgkin’s lymphoma (NHL). BTK is a nonreceptor kinase involved in B-cell survival, proliferation, and interaction with the microenvironment. …”
Get full text
Article -
366
Skeletal Muscle Lymphoma Presenting with Chronic Compartment Syndrome of Leg after Trauma
Published 2018-01-01“…Here, we report the first known case to be diagnosed with skeletal muscle-derived B-cell lymphoma presenting with chronic compartment syndrome after trauma. …”
Get full text
Article -
367
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells
Published 2025-02-01“…Therefore, the selective inhibition of the JAK2 pathway may potentiate CAR-T cell therapy and offer a viable treatment strategy for patients with resistant B-cell leukemias.…”
Get full text
Article -
368
Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome
Published 2025-01-01“…One signature, which contained multiple B-cell markers, was associated with immunotherapy efficacy in three cohorts, including IMvigor210. …”
Get full text
Article -
369
Unusual Initial Presentation of Herpes Simplex Virus as Inguinal Lymphadenopathy
Published 2015-01-01“…Histologic examination showed features consistent with viral lymphadenopathy, including florid follicular hyperplasia, monocytoid B-cell hyperplasia, and paracortical hyperplasia without extensive necrosis. …”
Get full text
Article -
370
Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
Published 2019-01-01“…If a monoclonal immunoglobulin other than IgMκ is found in a patient with CAD, the coexistence of two unrelated B-cell clones should be suspected.…”
Get full text
Article -
371
Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response
Published 2022-01-01“…Bach2 serves as a super enhancer and transcriptional repressor to control the differentiation and maturation of Th2-related immune cells such as B cell lineages and T cell lineages. In B cells, Bach2 is required for every stage of B cell development and can delay the class switch recombination and antibody-producing plasma cell differentiation. …”
Get full text
Article -
372
Characterisation of EfbA from the Endodontic Pathogen Enterococcus faecalis and Prediction of Immunodominant EfbA Epitope Peptides: An In-vitro and In-silico Study
Published 2025-01-01“…Aim: To predict the immunodominant B-cell and T-cell epitopes from the EfbA protein of E. faecalis. …”
Get full text
Article -
373
In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis
Published 2025-01-01“…The results revealed the identification of five promising cross-protective antigens. In total, 10 B-cell epitopes, 10 HTL epitopes, and 9 CTL epitopes were selected for the design of the vaccine. …”
Get full text
Article -
374
Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
Published 2016-01-01“…The as yet undescribed scenario of pro-B cell acute lymphoblastic leukemia arising in CALR mutated essential thrombocythemia is presented. …”
Get full text
Article -
375
Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature
Published 2020-01-01“…Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. …”
Get full text
Article -
376
In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging
Published 2008-11-01“…Rituximab is a chimeric monoclonal antibody directed against human CD20 antigen, which is expressed on B-cell lymphocytes and on the majority of B-cell lymphoid malignancies. …”
Get full text
Article -
377
Breast Mass and Lytic Bone Lesions: A Rare Presentation of Non-Hodgkin’s Lymphoma Arising in the Breast
Published 2013-01-01“…Biopsy of the mass revealed diffuse large B-cell lymphoma. Staging workup did not reveal any visceral organ or distant lymph node involvement. …”
Get full text
Article -
378
The Regulation between CD4+CXCR5+ Follicular Helper T (Tfh) Cells and CD19+CD24hiCD38hi Regulatory B (Breg) Cells in Gastric Cancer
Published 2022-01-01“…Tfh differentiation and CXCL13 were upregulated by cocultured B cells in vitro, while Tfh cells seem to not participate in Breg cell differentiation from B cells. …”
Get full text
Article -
379
Self-Centered Function of Adaptive Immunity in Regulation of Immune Responses and in Tolerance
Published 2021-01-01“…It is well established that the T/B cell repertoire is selected and maintained based on interactions with self. …”
Get full text
Article -
380
The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling
Published 2015-01-01“…Modeling interactions between aggregates and B cell receptors demonstrated that aggregates are unlikely to induce T cell-independent immune responses by cross-linking B cell receptors because the amount of signal transducing complex that can form under physiologically relevant conditions is limited. …”
Get full text
Article